Literature DB >> 19914098

DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study.

Varinderpal S Dhillon1, Eric Yeoh, Michael Fenech.   

Abstract

OBJECTIVE: Single nucleotide polymorphisms (SNPs) in DNA repair genes may impact on DNA damage, and cancer risk. To elucidate the role of SNPs in DNA repair genes in prostate cancer (PC) we conducted a case-control study comprising of 118 Caucasian men affected with late onset PC and 132 age-matched healthy controls from South Australia. METHODS AND MATERIALS: We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).
RESULTS: Prostate cancer risk was significantly increased only for carriers of the G allele of the C1245G polymorphism in the hOGG1 gene (OR = 2.28; 95% CI = 1.36-3.83; P = 0.002).
CONCLUSION: Our results suggest that this common nsSNP in a gene involved in repair of oxidative damage to DNA may contribute to PC susceptibility in South Australian men.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914098     DOI: 10.1016/j.urolonc.2009.08.013

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  30 in total

1.  Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.

Authors:  Fang Fang; Jia Wang; Lei Yao; Xiao-Jia Yu; Lu Yu; Long Yu
Journal:  Med Oncol       Date:  2010-06-12       Impact factor: 3.064

2.  XPD Asp312Asn polymorphism is a risk factor for prostate cancer.

Authors:  Shao-Guang Liao; Lu Liu; Ying Wang; Ying-Yi Zhang; Ya-Jie Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-29       Impact factor: 4.553

3.  Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Authors:  Bei-Bei Zhang; Dao-Gang Wang; Chao Xuan; Gui-Li Sun; Kai-Feng Deng
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

4.  ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.

Authors:  Elif Akisik; Hulya Yazici; Nejat Dalay
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

5.  The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.

Authors:  Gao Xuan; Ying Hui; He Fang
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

Review 6.  A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.

Authors:  Ping-Ting Zhou; Bo Li; Jun Ji; Meng-Meng Wang; Chun-Fang Gao
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

7.  Polymorphic Variation in Double Strand Break Repair Gene in Indian Population: A Comparative Approach with Worldwide Ethnic Group Variations.

Authors:  Raju Kumar Mandal; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2017-07-22

8.  Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.

Authors:  Hanna Romanowicz; Łukasz Pyziak; Filip Jabłoński; Magdalena Bryś; Ewa Forma; Beata Smolarz
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

9.  SNPs in ERCC1, ERCC2, and XRCC1 genes of the DNA repair pathway and risk of male infertility in the Asian populations: association study, meta-analysis, and trial sequential analysis.

Authors:  Vertika Singh; Sandeep Kumar Bansal; D V S Sudhakar; Arijit Chakraborty; Sameer Trivedi; Gopal Gupta; Kumarasamy Thangaraj; Singh Rajender; Kiran Singh
Journal:  J Assist Reprod Genet       Date:  2018-11-03       Impact factor: 3.412

10.  Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.

Authors:  Yuanyuan Mi; Lifeng Zhang; Ninghan Feng; Sheng Wu; Xiaoming You; Hongbao Shao; Feng Dai; Tao Peng; Feng Qin; Jiangang Zou; Lijie Zhu
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.